Zaransp. z o.o.
KRS: NIP: REGON:
Overview
Status
Active
Registry date
2004-09-24
Share capital
75 000,00 PLN
Registered address
Ciołka 17/408, 01-445 Warszawa, Poland
Financials
2 of the last 5 financial statements were filed late.
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 1.99mMedianUSD 382.03kAverageUSD 829.45k
Net profit
This companyUSD 12.67kMedianUSD 17.46kAverageUSD 69.49k
Operating costs
This companyUSD 1.98mMedianUSD 188.73kAverageUSD 743.88k
Assets
This companyUSD 282.14kMedianUSD 406.31kAverageUSD 607.61k
Industry
- Manufacture of articles of paper and paperboard (21.2)
- Manufacture of plastic products (25.2)
Bank accounts
Registered as a VAT taxpayer on 2004-10-15.
29 1160 2202 0000 0001 2443 9351
17 1160 2202 0000 0000 4740 0615
30 1020 1169 0000 8102 0917 3461
Debt
No entries in the National Debtors Register (KRZ).
Public aid
No public aid cases recorded in the last 10 years.
Authorized Representatives
Andrzej Jan Zaręba – President of the Management Board
Eliza Maria Zaręba – Vice President of the Management Board
Manner of representation
Each member of the management board independently.
Ownership
| Owner |
|---|
Andrzej Jan Zaręba (56) |
Eliza Maria Zaręba (54) |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Anpharm Przedsiębiorstwo FarmaceutyczneS.A. | $111,469,394.21 | anpharm.pl | ||
| VercoS.A. | $43,577,172.02 | verco.com.pl | ||
| MedicofarmaS.A. | $8,530,473.72 | medicofarma.pl | ||
| VitamaS.A. | $4,287,087.38 | vitama.pl | ||
| Biotriosp. z o.o. | $453,662.22 | biotrio.pl | ||
| Munar PharmaS.A. | $85,649.72 | munar.pl | ||
| Bioresearch PharmaS.A. | $21,432.15 | bioresearchpharma.com | ||
| Sanford Biotechsp. z o.o. | $2,586.64 | sanfordbiotech.com | ||
| Cefeasp. z o.o. | $294.66 | cefea.pl | ||
| Auxilius PharmaS.A. | $0.83 | auxiliuspharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2008-08-20 | Address change (Tawerny 3/6, 02-654, Warszawa → Ciołka 17/408, 01-445, Warszawa) | |
| 2007-04-23 | Address change (Włodarzewska 59b/9, 02-384, Warszawa → Tawerny 3/6, 02-654, Warszawa) | |
| 2004-09-24 | Entered in the register |
FAQ
The company was registered in the Polish National Court Register (KRS) on September 24, 2004.
The headquarters is located at: Ciołka 17, 01-445 Warszawa.
The share capital of the company is PLN 75,000 (approx. $20,259).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $1,993,245, representing an increase of 7999.0% compared to 2024.
Yes, in 2025 the company achieved a net profit of $12,673.
The largest operating cost category falls under cost of goods and materials sold. This category amounted to $1,933,752 in 2025, representing 98% of all operating expenses.
Last updated: 2026-07-15